Scholarlink

<p>Recent evidence links gut dysbiosis and the gut-brain axis to the pathophysiology of Parkinson’s disease (PD), which is considered one of the most common neurodegenerative illnesses and is characterized by motor symptoms and a gradual loss of nigral dopaminergic neurons. Canagliflozin (CANA), a sodium–glucose cotransporter-2 inhibitor with emerging anti-inflammatory and antioxidant properties, has recently gained attention for its neuroprotective effects beyond glycemic control. This research aimed to examine the neuroprotective potential of CANA in a rat model of PD, focusing on its potential effect on the gut-inflammasome–brain axis. Rats were treated with rotenone&#xa0;(ROT) (2&#xa0;mg/kg, subcutaneous) and/or CANA (20&#xa0;mg/kg, oral) for 30 consecutive days. Behavioral assessment (<i>n</i> = 13), biochemical assays (<i>n</i> = 6), and histological and immunohistochemical analysis (<i>n</i> = 3) were performed. Microbiome profiling (<i>n</i> = 3) using 16S rRNA amplicon sequencing was conducted using three pooled fecal samples/group, with each pool prepared from fecal material collected from three rats and fecal metabolomic profiling (<i>n</i> = 5) was performed to assess microbial metabolites. ROT intoxication caused significant motor impairments, including decreased locomotor activity, poor coordination, and increased catalepsy. Further histological examination demonstrated dopaminergic neuronal loss and α-synuclein aggregation in the substantia nigra and striatum. CANA treatment enhanced motor function, conserved neuronal integrity, and decreased α-synuclein accumulation. Moreover, ROT altered the gut microbiota with selective taxonomic shifts, including enriched abundance of <i>Parabacteroides</i> and <i>Ruminococcaceae</i> with depleted <i>Prevotella</i>-related taxa, in addition to fecal metabolite profile alteration. Consequently, it increased colonic oxidative stress and weakened tight junctions, all of which enhanced LPS translocation. This systemic endotoxemia generated oxidative stress, dyslipidemia, and NF-κB/NLRP3 inflammasome activation. Conversely, CANA restored gut microbial balance and their metabolites, and gut integrity, decreased LPS leakage, and reduced systemic and central oxidative stress and inflammation, preventing inflammasome activation and α-synuclein aggregation. Collectively, these findings suggest that CANA may exert neuroprotective effects in ROT-induced PD associated with modulating the gut-inflammasome–brain axis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Canagliflozin attenuates Parkinson’s disease and is associated with modulation of gut-inflammasome–brain axis in rats

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月22日

查看全文
  • Nada K. Gamal,
  • Rafik Fakhry,
  • Youmna Hatem,
  • Engy Rashed,
  • Reem Marzouk,
  • Ahmed K. M. Bukr,
  • Kerolos Safwat,
  • Mohamed Mamdouh,
  • Ahmed AbdElFatah,
  • Abdelrahman Atallah,
  • Heba Attia,
  • Iriny M. Ayoub,
  • Mina Y. George

摘要

Recent evidence links gut dysbiosis and the gut-brain axis to the pathophysiology of Parkinson’s disease (PD), which is considered one of the most common neurodegenerative illnesses and is characterized by motor symptoms and a gradual loss of nigral dopaminergic neurons. Canagliflozin (CANA), a sodium–glucose cotransporter-2 inhibitor with emerging anti-inflammatory and antioxidant properties, has recently gained attention for its neuroprotective effects beyond glycemic control. This research aimed to examine the neuroprotective potential of CANA in a rat model of PD, focusing on its potential effect on the gut-inflammasome–brain axis. Rats were treated with rotenone (ROT) (2 mg/kg, subcutaneous) and/or CANA (20 mg/kg, oral) for 30 consecutive days. Behavioral assessment (n = 13), biochemical assays (n = 6), and histological and immunohistochemical analysis (n = 3) were performed. Microbiome profiling (n = 3) using 16S rRNA amplicon sequencing was conducted using three pooled fecal samples/group, with each pool prepared from fecal material collected from three rats and fecal metabolomic profiling (n = 5) was performed to assess microbial metabolites. ROT intoxication caused significant motor impairments, including decreased locomotor activity, poor coordination, and increased catalepsy. Further histological examination demonstrated dopaminergic neuronal loss and α-synuclein aggregation in the substantia nigra and striatum. CANA treatment enhanced motor function, conserved neuronal integrity, and decreased α-synuclein accumulation. Moreover, ROT altered the gut microbiota with selective taxonomic shifts, including enriched abundance of Parabacteroides and Ruminococcaceae with depleted Prevotella-related taxa, in addition to fecal metabolite profile alteration. Consequently, it increased colonic oxidative stress and weakened tight junctions, all of which enhanced LPS translocation. This systemic endotoxemia generated oxidative stress, dyslipidemia, and NF-κB/NLRP3 inflammasome activation. Conversely, CANA restored gut microbial balance and their metabolites, and gut integrity, decreased LPS leakage, and reduced systemic and central oxidative stress and inflammation, preventing inflammasome activation and α-synuclein aggregation. Collectively, these findings suggest that CANA may exert neuroprotective effects in ROT-induced PD associated with modulating the gut-inflammasome–brain axis.